Pentracor Healthcare Technology GmbH

Pentracor Healthcare Technology GmbH, based in Kleinmachnow, is a medical technology company specializing in the development of innovative methods for the targeted control of inflammatory processes. The company's activities focus on the research and application of technologies for the selective removal of C reactive protein from the blood. C reactive protein is a central component of the immune response and has long been used clinically as a marker for inflammation. However, it also plays an active role in the inflammatory process by, among other things, binding to damaged cells, activating the complement system and thus enhancing immunological reactions. Excessive activation of these mechanisms can contribute to additional tissue damage. Against this background, Pentracor is pursuing a novel therapeutic approach in which C reactive protein is specifically removed from the blood in order to modulate excessive inflammatory reactions.

Pentracor positions itself as a specialized provider in the field of extracorporeal blood purification with a clear focus on the functional role of C reactive protein in inflammatory processes. By combining biomedical research and technological development, the company aims to provide innovative treatment options for patients with severe inflammatory diseases.